Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase.

scientific article published on March 1997

Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase. is …

instance of (P31):

scholarly article

External links are

PubMed publication ID

P2093	author name string	Li Z
		Seth P
		Srivastava S
		Huber B
		Cowan K
		Katayose D
		Shanmugam N
P433	issue	2
P921	main subject	Escherichia coli	Q25419
		Adenoviridae	Q193447
		gene therapy	Q213901
P304	page(s)	113-117
P577	publication date	1997-03-01
P1433	published in	Cancer Gene Therapy	Q15763088
P1476	title	Enzyme/prodrug gene therapy approach for breast cancer using a recombinant adenovirus expressing Escherichia coli cytosine deaminase
P478	volume	4

Reverse relations

cites work (P2860)

Q38090923	Encapsulated stem cells for cancer therapy
Q40382089	Experimental studies on PNP suicide gene therapy of hepatoma
Q38262019	Gene-directed enzyme prodrug therapy
Q33614725	Human nerual stem cells for brain repair
Q39137284	Neural stem cell-based gene therapy for brain tumors
Q40217087	Prodrug-activating Gene Therapy with Rabbit Cytochrome P450 4B1/4-Ipomeanol or 2-Aminoanthracene System in Glioma Cells.
Q24792836	Prodrugs for Gene-Directed Enzyme-Prodrug Therapy (Suicide Gene Therapy)
Q36645679	Stem cells with fused gene expression of cytosine deaminase and interferon-β migrate to human gastric cancer cells and result in synergistic growth inhibition for potential therapeutic use.